Currently, people with Medicare cannot appeal the decision to classify them outpatients, but a court case—Alexander v. Azar—may change that. In 2011, seven plaintiffs filed a class action lawsuit to try to gain the right to appeal the decision to classify them as outpatients in observation stay instead of as inpatients who would potentially be eligible for SNF coverage. After many twists and turns, the case has finally made it to trial this week in a Connecticut court. If successful, the lawsuit would ensure that beneficiaries can appeal decisions made by hospitals that reduce their eligibility for Medicare coverage of SNF care.

On June 14, the Department of Health and Human Services (HHS) issued a proposed rule that would significantly weaken the Affordable Care Act’s (ACA) nondiscrimination protections. Section 1557 of the ACA makes it illegal for providers that receive federal funding to discriminate in the provision of health care on the basis of race, color, national origin (including language access), age, disability or sex. HHS is now seeking to limit those protections, changes that would put many already vulnerable populations—including older adults, people with disabilities, people with limited English proficiency, and LGBTQ individuals—at risk of losing access to care.

The Centers for Medicare & Medicaid Services recently announced a proposal designed to increase hospital price transparency. Under the draft

A new report from the AARP Public Policy Institute examines changes to Medicare Advantage (MA) supplemental benefit policies and the implications for people with Medicare.

MA plans have long been able to offer benefits beyond what is required by law. However, the recent Balanced Budget Act of 2018 and regulatory decisions, including those in the 2019 Part C and D final rule and the Final Call Letter for 2019, have greatly increased this authority.

Medicare Plan Finder (MPF) is a primary way for people with Medicare to understand and compare their coverage choices. MPF should allow beneficiaries, caregivers, and unbiased counselors to find the coverage that best serves the needs of the individual. A new report from the U.S. Government Accountability Office (GAO) agrees with previous research on MPF that the tool has significant problems that interfere with its usefulness.

A new study reveals that Medicaid expansion has reduced deaths in states where it has been adopted. By contrast, in states that have refused to expand their Medicaid coverage, approximately 15,600 people have died as a result. This study is the first large-scale assessment of the effect of Medicaid expansion on mortality.

This week, the Senate Finance Committee unveiled long-awaited drug pricing legislation, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. The bill outlines a number of changes to address the problem of high and rising drug prices within the Medicare program, including a redesign of the Part D benefit and the imposition of inflationary rebates.

The Department of Health and Human Services, Office of Inspector General (OIG) recently released two reports on the Medicare hospice

Last week, the Trump administration decided to shelve a proposed rule that sought to change the way Medicare prescription drug

A rule from the Trump administration that sought to require prescription drug manufacturers to include pricing information in their television